Morgan Stanley, Leerink, Cantor Fitzgerald and Stifel acted as joint book running managers for the offering.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRVI:
- Closing Bell Movers: Netflix down 9% as Q2 outlook misses, Hastings leaves board
- Trevi Therapeutics announces $150M common stock offering
- Trevi Therapeutics: Positive Needham Conference Takeaways Reinforce Buy Rating and Favorable Risk‑Reward Profile
- Trevi Therapeutics price target lowered to $24 from $25 at JonesResearch
- Trevi Therapeutics Maps Phase III Path and Runway